Newly published data suggests low competition among middling players in the pharmaceutical supply chain, with numbers showing that the four largest pharmacy benefit managers in the country control ...
The four largest pharmacy benefit managers in the U.S. control 70% of the national market, and most regional PBM markets are highly concentrated, according to new data from the American Medical ...
The pharmaceutical supply chain is a sector infamous for glacially slow adjustments, lackluster reform, lack of transparency and massive anti-competitive conglomerates. Years of dominance by the three ...
A new analysis from the American Medical Association (AMA) adds to the growing evidence detailing the lack of competition and high vertical integration in the pharmacy benefit manager market. The ...
A new study is raising red flags about the composition of market power among pharmacy benefit managers, powerful middlemen in the drug supply chain that are facing heavy scrutiny for their alleged ...
Expertise and opinions of authors published by ForbesBooks. Imprint operated under license. In my last article, which was devoted to the causes of dramatically rising prescription drug costs and ...
WASHINGTON, Sept 20 (Reuters) - The U.S. Federal Trade Commission said on Friday it was suing the country's three largest pharmacy benefit managers, accusing them of abusing their power and rigging ...
A recent proposal by Tennessee State Sen. Bobby Harshbarger that would ban any pharmacy benefit manager (PBM) from also operating a pharmacy inside the state of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback